101 related articles for article (PubMed ID: 3871702)
1. B cell activation and adjuvant activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A.
Kumazawa Y; Matsuura M; Homma JY; Nakatsuru Y; Kiso M; Hasegawa A
Eur J Immunol; 1985 Feb; 15(2):199-201. PubMed ID: 3871702
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
[TBL] [Abstract][Full Text] [Related]
3. Effect of stereospecificity of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-40 on the expression of immunopharmacological activities.
Kumazawa Y; Ikeda S; Takimoto H; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Eur J Immunol; 1987 May; 17(5):663-7. PubMed ID: 3495442
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic and polyclonal B cell activation activities of synthetic lipid A analogues.
Kumazawa Y; Matsuura M; Nakatsuru-Watanabe Y; Fukumoto M; Nishimura C; Homma JY; Inage M; Kusumoto S; Shiba T
Eur J Immunol; 1984 Feb; 14(2):109-14. PubMed ID: 6199209
[TBL] [Abstract][Full Text] [Related]
5. Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.
Ikeda S; Matsuura M; Nakatsuka M; Homma JY; Kiso M; Hasegawa A; Nishimura C
J Clin Lab Immunol; 1990 Aug; 32(4):177-81. PubMed ID: 1966934
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A.
Matsuura M; Kojima Y; Homma JY; Kubota Y; Yamamoto A; Kiso M; Hasegawa A
FEBS Lett; 1984 Feb; 167(2):226-30. PubMed ID: 6698210
[TBL] [Abstract][Full Text] [Related]
7. Effects of backbone structures and stereospecificities of lipid A-subunit analogues on their biological activities.
Matsuura M; Kojima Y; Homma JY; Kumazawa Y; Yamamoto A; Kiso M; Hasegawa A
J Biochem; 1986 May; 99(5):1377-84. PubMed ID: 3486867
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of chemically synthesized analogues of lipid A. Demonstration of adjuvant effect in hapten-sensitized liposomal system.
Yasuda T; Kanegasaki S; Tsumita T; Tadakuma T; Homma JY; Inage M; Kusumoto S; Shiba T
Eur J Biochem; 1982 May; 124(2):405-7. PubMed ID: 7047163
[TBL] [Abstract][Full Text] [Related]
9. The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice.
Tanamoto K; Azumi S; Haishima Y; Kumada H; Umemoto T
J Immunol; 1997 May; 158(9):4430-6. PubMed ID: 9127008
[TBL] [Abstract][Full Text] [Related]
10. Synthetic glycolipid adjuvants.
Behling UH; Campbell B; Chang CM; Rumpf C; Nowotny A
J Immunol; 1976 Sep; 117(3):847-51. PubMed ID: 60450
[TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity.
Jiang ZH; Budzynski WA; Qiu D; Yalamati D; Koganty RR
Carbohydr Res; 2007 May; 342(6):784-96. PubMed ID: 17300769
[TBL] [Abstract][Full Text] [Related]
12. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
[TBL] [Abstract][Full Text] [Related]
13. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
[TBL] [Abstract][Full Text] [Related]
14. Ionophorous activity and murine B lymphocyte mitogens.
Rosenstreich DL; Blumenthal R
J Immunol; 1977 Jan; 118(1):129-36. PubMed ID: 299751
[TBL] [Abstract][Full Text] [Related]
15. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements of lipid A for endotoxicity and other biological activities.
Takada H; Kotani S
Crit Rev Microbiol; 1989; 16(6):477-523. PubMed ID: 2663021
[TBL] [Abstract][Full Text] [Related]
17. Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.
Kotani S; Takada H; Tsujimoto M; Ogawa T; Mori Y; Sakuta M; Kawasaki A; Inage M; Kusumoto S; Shiba T; Kasai N
Infect Immun; 1983 Aug; 41(2):758-73. PubMed ID: 6409812
[TBL] [Abstract][Full Text] [Related]
18. C57BL/10/CR mice: nonresponders to activation by the lipid a moiety of bacterial lipopolysaccharide.
McAdam KP; Ryan JL
J Immunol; 1978 Jan; 120(1):249-53. PubMed ID: 342603
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity.
Fujimoto Y; Adachi Y; Akamatsu M; Fukase Y; Kataoka M; Suda Y; Fukase K; Kusumoto S
J Endotoxin Res; 2005; 11(6):341-7. PubMed ID: 16303089
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis.
Sawada N; Ogawa T; Asai Y; Makimura Y; Sugiyama A
Clin Exp Immunol; 2007 Jun; 148(3):529-36. PubMed ID: 17335558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
